L

Standard BioTools
D

LAB

1.05500
USD
0.06
(6.16%)
مغلق
حجم التداول
80,749
الربح لكل سهم
-0
العائد الربحي
-
P/E
-3
حجم السوق
381,110,593
أصول ذات صلة
A
A
1.780
(1.56%)
115.760 USD
ABT
ABT
-0.390
(-0.29%)
133.530 USD
ALGN
ALGN
0.450
(0.25%)
180.690 USD
BDX
BDX
2.340
(1.37%)
173.400 USD
IDXX
IDXX
2.59
(0.50%)
525.15 USD
ILMN
ILMN
0.330
(0.40%)
82.630 USD
MRK
MRK
1.275
(1.64%)
78.935 USD
PODD
PODD
-5.61
(-1.77%)
311.55 USD
REGN
REGN
10.27
(2.13%)
493.12 USD
TMO
TMO
3.69
(0.93%)
401.77 USD
T
TNDM
0.135
(0.65%)
20.785 USD
ZTS
ZTS
1.350
(0.80%)
170.000 USD
المزيد
الأخبار المقالات

العنوان: Standard BioTools

القطاع: Healthcare
الصناعة: Medical Devices
Standard BioTools Inc develops, manufactures, and sells technologies that help biomedical researchers in their search for developing medicines faster. Its tools provide insights into health and disease using proprietary mass cytometry and microfluidics technologies, which serve applications in proteomics and genomics, respectively. Its segments include Proteomics and Genomics. It generates maximum revenue from the Proteomics segment. Geographically, it derives a majority of its revenue from the Americas.